Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 59 enzyme PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


enzyme PhD Projects, Programmes & Scholarships

We have 59 enzyme PhD Projects, Programmes & Scholarships

Last chance to apply

De-novo palladium-containing enzymes

Background. This project will be carried out in collaboration with Johnson-Matthey. Metalloenzymes are critical for catalyzing a wide range of biochemical transformations, including biomass degradation. Read more

Wearable Sample Collection for Biosensing

Measurement of low abundance proteins is key for enabling early detection of diseases [1]. A widely used method for the measurement of low abundance proteins is enzyme-linked immunosorbent assay (ELISA) [2]. Read more

Wall Teichoic Acid biosynthesis inhibitors to fight antibiotic resistance

Background and aims. Antibiotic resistance is a growing threat to human health. In 2019, more than 1.2 million people died globally as a result of antimicrobial resistant bacterial infections; of these, more than 100,000 deaths were attributed to methicillin-resistant Staphylococcus aureus (MRSA). Read more

Catalytic nanocages for in situ drug delivery

Therapeutic nanoreactors are innovative nanocompartments that confine one or more biocatalysts (e.g., enzymes) for the in-situ production of therapeutic agents, enabling targeted drug delivery with minimal off-site toxicity. Read more

Molecular mechanisms underpinning A. baumannii virulence

 . Antimicrobial resistance (AMR) is a major public health threat. Acinetobacter baumannii, is the leading cause of nosocomial infections worldwide, where its high resistance to antibiotic treatments and ability to cause lethal infections, has led to its categorisation as a “critical priority” pathogen by the WHO1. Read more

Comprehensive investigation of the impact of proglucagon gene and GIP gene products on metabolic control

  Research Group: Biomedical Sciences
New and highly effective drugs for the treatment of obesity and diabetes, such as liraglutide (Victoza®, Saxenda®), semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are essentially derived from products of the proglucagon and GIP genes. Read more

Filtering Results